Lisanti Capital Growth, LLC Ligand Pharmaceuticals Inc Transaction History

Lisanti Capital Growth, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 13, 2019	SELL	$105.93 - $142.47 $1.16 Million - $1.56 Million	-10,980 Closed	0 $0
Q4 2018 Feb 08, 2019	SELL	$128.36 - $272.13 $680,308 - $1.44 Million	-5,300 Reduced 32.56%	10,980 $1.49 Million
Q3 2018 Nov 05, 2018	BUY	$211.18 - $274.49 $417,080 - $542,117	1,975 Added 13.81%	16,280 $4.47 Million
Q2 2018 Aug 13, 2018	BUY	$150.77 - $207.98 $146,246 - $201,740	970 Added 7.27%	14,305 $2.96 Million
Q1 2018 May 15, 2018	BUY	$138.63 - $182.62 $1.85 Million - $2.44 Million	13,335 New	13,335 $2.2 Million

248

17.7M

61K

7.8K

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $1.78B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

Get notified when there are updates to the investment portfolio of Lisanti Capital Growth, LLC, based on Form 13F filings with the SEC.

Stay updated on Lisanti Capital Growth, LLC with notifications on news.